Reckitt Benckiser Group has signed an agreement to offload its Infant Formula and Child Nutrition (IFCN) business in China to private equity firm Primavera Capital Group for $2.2 billion. Upon completion of the transaction, Primavera will have a royalty-free perpetual and exclusive licence of the Mead Johnson and Enfa family of brands (which includes Enfinitas, Enfamil…
Login or subscribe to read the full article
Subscribe Free Today
Get full access to the site and the latest industry news and insights delivered straight to your inbox – free. Canmaking News will keep you informed through our weekly news alerts.